Development of genotoxic impurities guidelines and their impact on regulatory review

被引：0

作者：

Klenke, Elisabeth ^{[1
]}

机构：

[1] Swissmedic, Bern, Switzerland

来源：

TOXICOLOGY LETTERS | 2013年 / 221卷

关键词：

RISK;

D O I：

10.1016/j.toxlet.2013.06.053

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

引用

页码：S15 / S15

页数：1

共 50 条

[1] Overall impact of the regulatory requirements for genotoxic impurities on the drug development process
Giordani, Antonio
Kobel, Werner
Gally, Hans Ulrich
[J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 43 (1-2) : 1 - 15
[2] IMPURITIES IN PHARMACEUTICAL PRODUCTS: AN OVERVIEW OF REGULATORY GUIDELINES, EMERGING DETECTION METHODS, RESIDUAL SOLVENTS AND GENOTOXIC ASPECTS
Dragan, Andreea G.
Cinteza, Otilia L.
Weisssieker, Horst
Schaff, Peter
[J]. FRESENIUS ENVIRONMENTAL BULLETIN, 2009, 18 (01): : 3 - 11
[3] Genotoxic Impurities: A Regulatory Toxicology Commentary on Recent Articles in Organic Process Research & Development
Snodin, David J.
[J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2011, 15 (06) : 1243 - 1246
[4] Overview of Genotoxic Impurities in Pharmaceutical Development
Bercu, Joel P.
Dobo, Krista L.
Gocke, Elmar
McGovern, Timothy J.
[J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2009, 28 (06) : 468 - 478
[5] Evolution of regulatory aspects of genotoxic impurities in pharmaceuticals: Survival of the fittest
Maithani, Mukesh
Raturi, Richa
Gupta, Vikas
Bansal, Parveen
[J]. JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2017, 40 (15) : 759 - 769
[6] Review of Genotoxic Impurities: Strategies for Identification and Control
Theresa Allio
[J]. Drug information journal : DIJ / Drug Information Association, 2012, 46 (2): : 235 - 236
[7] Controlling of genotoxic impurities in pharmaceuticals: International harmonisation of regulatory requirements
Kasper, P.
[J]. TOXICOLOGY LETTERS, 2011, 205 : S7 - S7
[8] GENOTOXIC IMPURITIES
Thayer, Ann M.
[J]. CHEMICAL & ENGINEERING NEWS, 2010, 88 (39) : 16 - +
[9] Genotoxic Impurities
Laird, Trevor
[J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2009, 13 (03) : 363 - 363
[10] Genotoxic impurities in excipients: regulatory implications for International Pharmaceutical Excipients Council
Mroz, C.
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A78 - A79

← 1 2 3 4 5 →